New York State Common Retirement Fund
ANTX icon

New York State Common Retirement Fund’s AN2 Therapeutics ANTX Stock Holding History

New York State Common Retirement Fund’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-101
Closed -$859 – 3271
2023
Q2 		$859 Sell
101
-5,778
-98% -$41.5K ﹤0.01% 3324
2023
Q1 		$58K Buy
5,879
+54
+0.9% +$600 ﹤0.01% 2955
2022
Q4 		$55.5K Hold
5,825
– – ﹤0.01% 3074
2022
Q3 		$101K Sell
5,825
-5,575
-49% -$65K ﹤0.01% 3008
2022
Q2 		$88K Buy
+11,400
New +$151K ﹤0.01% 3113

Other funds holding ANTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

New York State Common Retirement Fund's ANTX Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of AN2 Therapeutics (ANTX) in Q3 2023, closing a stake of 101 shares — an estimated $859 sold.

New York State Common Retirement Fund first reported a position in ANTX in Q2 2022 and held it in 5 quarters. The position peaked at $101K in Q3 2022. 37 funds tracked by Wall St. Rank hold ANTX as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining AN2 Therapeutics position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 101 AN2 Therapeutics shares in Q3 2023, an estimated $859.
  • New York State Common Retirement Fund first reported a position in AN2 Therapeutics in Q2 2022 and held it in 5 quarters.
  • New York State Common Retirement Fund's AN2 Therapeutics position peaked at $101K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.